Multivariate analysis revealed that the BMI was an independent risk factor for the prognosis of HCC patients with BCLC stage-B disease (P = 0.001), along with APTT and serum AST, ALB, TB, and AFP levels (Table 3). This evidence concerns the gene ALB and hepatocellular carcinoma.